Immediate Impact
1 by Nobel laureates 58 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Current and future immunotherapeutic approaches in pancreatic cancer treatment
2024 Standout
Works of Devora Delman being referenced
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
2024
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Devora Delman | 65 | 36 | 86 | 51 | 8 | 172 | |
| Yamel Cardona Gloria | 43 | 119 | 93 | 13 | 11 | 214 | |
| Eva Grundschober | 108 | 127 | 89 | 82 | 6 | 271 | |
| Lynn McCallum | 35 | 49 | 205 | 55 | 13 | 285 | |
| Verena Kalter | 39 | 79 | 44 | 21 | 8 | 145 | |
| Thomas S. Fulford | 51 | 174 | 76 | 12 | 8 | 269 | |
| Hong L. Tiv | 38 | 22 | 65 | 49 | 7 | 126 | |
| Tao Li | 43 | 43 | 122 | 22 | 12 | 206 | |
| Minfang Song | 47 | 41 | 97 | 6 | 12 | 164 | |
| Matteo Marchesini | 41 | 21 | 96 | 48 | 13 | 163 | |
| Jorge Vaz Pinto Neto | 49 | 17 | 103 | 36 | 6 | 172 |
All Works
Loading papers...